GOYAL ARJUN
SEC insider (Form 3/4/5 filer). CIK 0001861844. Director at JATT III Acquisition Corp (JTTT) and 2 other issuers. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in CHESHIRE.
Companies GOYAL ARJUN has filed insider reports for
- JATT III Acquisition Corp (JTTT): Director
- Centessa Pharmaceuticals plc (CNTA): Director
- JATT II Acquisition Corp. (JATT): Director
GOYAL ARJUN
CIK: 0001861844
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 24, 2026CNTA
Centessa Pharmaceuticals plc
DispositionIndirect462.6K shares- - Jun 20, 2025CNTA
Centessa Pharmaceuticals plc
AwardDirectShare Option (right to buy)
40K shares- - May 16, 2025CNTA
Centessa Pharmaceuticals plc
PurchaseIndirect417.6K shares at avg. $12.73$5.3M - May 15, 2025CNTA
Centessa Pharmaceuticals plc
PurchaseIndirect44.9K shares at avg. $12.24$550K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 24, 2026 |  CNTA Centessa Pharmaceuticals plc | Disposition | 462,585 | - | $0 | Indirect |
| Jun 20, 2025 | CNTA Centessa Pharmaceuticals plc | Award Share Option (right to buy) | 40,000 | - | - | Direct |
| May 16, 2025 | CNTA Centessa Pharmaceuticals plc | Purchase | 417,646 | $12.73 | $5,315,005 | Indirect |
| May 15, 2025 | CNTA Centessa Pharmaceuticals plc | Purchase | 44,939 | $12.24 | $550,238 | Indirect |
1-4 of 4 transactions